Analysis of heart period and arterial pressure variability in childhood hypertension: Key role of baroreflex impairment

Hypertension

Volumn 51, Issue 5, 2008, Pages 1289-1294

  Genovesi, Simonetta ^a,b   Pieruzzi, Federico ^a,b   Giussani, Marco ^c   Tono, Valentina ^a   Stella, Andrea ^a,b   Porta, Alberto ^d   Pagani, Massimo ^e   Lucini, Daniela ^e  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c Federazione Italiana Medici Pediatri   (Italy)

^d IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Autonomic nervous system; Baroreceptors; Hypertension; Lifestyle; Pediatrics

Indexed keywords

ARTERIAL PRESSURE; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE VARIABILITY; BODY MASS; CARDIOVASCULAR DISEASE; CHILD; CHILDHOOD HYPERTENSION; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL;

AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; BLOOD PRESSURE; BODY HEIGHT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; PRESSORECEPTORS;

EID: 42349096698     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.109389     Document Type: Article

References (38)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
2. Kearney PM, Whelton M, Reynolds K, Munter P, Whelton PK, He J. Global burden of hypertension:analysis of worldwide data. Lancet. 2005;365:217-233.
3. Wellens HJJ. Cardiology: where to go from here? Lancet. 1999; 354(suppl):SIV8.
4. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study):case control study. Lancet. 2004;364:937-952.
5. Stampfer MJ, Hu FB, Manson JAE, Rimm EB, Willet WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16-22.
6. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
7. Kikuya M, Hansen TW, Thijs L, Björklund-Bodegârd K, Kuznetsova T, Ohkubo T, Richart T, Pachiaudi C, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA, on behalf of the International Database of Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;2:2145-2152.
8. Lichtenstein AH, Appel LJ, Carnethon M, Franch HA, Kris-Etherton P, Howard B, Lefevre M, Sacks F, Winston M. Diet and lifestyle recommendations revision 2006. A scientific statement from the Am Heart Association Nutrution Committee. Circulation. 2006;114:82-96.
9. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-396.
10. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-2374.
11. Daniels SR, Arnett DK, Eckel R, Gidding SS, Hayman LL, Kumanyika SK, Robinson TN, Scott BJ, StJeor S. Overweight in children and adolescents. Circulation. 2005;111:1999-2012.
12. Eckel RH, Daniels SR, Jacobs AK, Robertson RM. America's children. A critical time for prevention. Circulation. 2005;111:1866-1868.
13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The forth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-576.
14. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa heart Study. Am J Hypertens. 2007;8:657-665.
15. Greenwood JP, Stoker JB, Mary D. Single-unit sympathetic discharge - quantitative assessment in human hypertensive disease. Circulation. 1999;100:1305-1310.
16. Lucini D, Mela GS, Malliani A, Pagani M. Impairment in cardiac autonomic regulation preceding arterial hypertension in humans. Insights from spectral analysis of beat-by-beat cardiovascular variability. Circulation. 2002;106:2673-2679.
17. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla G, Mancia G. Effects of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensive. J Hypertens. 2004;22:2363-2369.
18. Bravo PE, Morse S, Borne DM, Aguilar EA, Reisin E. Leptin and hypertension in obesity. Vasc Hralth Risk Manag. 2006;2:163-169.
19. Genovesi S, Giussani M, Pieruzzi F, Vigorita F, Arcovio C, Cavuto S, Stella A. Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight. J Hypertens. 2005;23:493-497.
20. Badilini F, Pagani M, Porta A. Heartscope: a software tool addressing autonomic nervous system regulation. Comput Cardiol. 2005;32:259-262.
21. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, Turiel M, Baselli G, Cerutti S, Malliani A. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res. 1986;58:178-193.
22. Pagani M, Montano N, Porta A, Malliani A, Abboud FM, Birkett CL, Somers VK. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation. 1997;95:1441-1448.
23. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482-492.
24. Porta A, Guzzetti S, Montano N, Pagani M, Somers VK, Malliani A, Baselli G, Cerutti C. Information domain analysis of cardiovascular variability signals: evaluation of regularity, synchronisation and co-ordination. Med Biol Eng Comput. 2000;38:180-188.
25. Bertinieri G, Di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G. A new approach to analysis of the arterial baroreflex. J Hypertens. 1985;3:S79-S81.
26. Pagani M, Somers VK, Furlan R, Dell'Orto S, Conway J, Baselli G, Cerutti S, Sleight P, Malliani A. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension. 1988;12:600-610.
27. Bristow JD, Honour AJ, Pickering GW, Sleight P, Smyth HS. Diminished baroreflex sensitivity in high blood pressure. Circulation. 1969;39:48-54.
28. Parati G, Di Rienzo M, Bertinieri G, Pomidossi G, Casadei R, Groppelli A, Pedotti A, Zanchetti A, Mancia G. Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arteria blood pressure monitoring in humans. Hypertension. 1988;12:214-222.
29. Lande MB, Carson NL, Roy J, Meagher CC. Effects of childhood primary hypertension on carotid intima media thickness. A matched controlled study. Hypertension. 2006;48:40-44.
30. Brown AM. Receptors under pressure. An update of baroreceptors. Circ Res. 1980;46:1-10.
31. Laude D, Elghozi JL, Girard A, Bellard E, Bouhaddi M, Castiglioni P, Cerutti C, Cividjian A, Di RM, Fortrat JO, Janssen B, Karemaker JM, Leftheriotis G, Parati G, Persson PB, Porta A, Quintin L, Regnard J, Rudiger H, Stauss HM. Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol. 2004;286:R226-R231.
32. Pagani M. To dip or not to dip of arterial pressure physiology, system's analysis and information. Hypertension. 2007;491-492.
33. de Simone G, Wachtell K, Palmieri V, Hille DA, Beevers G, Dahlõf B, de Faire U, Fyhrquist F, Ibsen H, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Devereux RB. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) Study. Circulation. 2005;111:1924-1931.
34. Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension. 1993;21:886-893.
35. Willet WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296:695.
36. Whaley MD, ed. ACSM'S Guidelines for Exercise and Prescription. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
37. Kavey RE, Kveselis DA, Atallah N, Smith FC. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr. 2007;150:491-497.
38. Turner ST, Schwartz GL, Boerwinkle E. Personalized medicine for high blood pressure. Hypertension. 2007;50:1-5.